Epidemiological Rationale for Changing the Strategy and Tactics of Vaccination of Pertussis in Current Conditions
https://doi.org/10.31631/2073-3046-2019-18-2-27-33
Abstract
A research objective – definition of the main directions of improvement of epidemiological control of a pertussis on the basis of studying of manifestations of epidemic process and its determinants. Materials and methods. The analysis of incidence is carried out according to official statistics in 19 years, the population antipertussoid immunity is studied by results of routine serological monitoring and specially organized screening researches. At discussion of results and development of recommendations WHO recommendations and the published articles of domestic and foreign authors are used. Results. Activation of epidemic process of pertussis in modern conditions in all age groups of the population is revealed. Risk factors of incidence of children about one year and the main sources of their infection, low level of a seroprotektion at children of 3–4 years old, the hidden circulation of Bordetella pertussis in group of children of 6-7 years, high susceptibility to whooping cough of adult population, including pregnant women are established. Conclusion. The directions of optimization of vaccinal prevention of pertussis are defined: strengthening of supervising functions behind completeness and timeliness of immunization of children of the first year of life; wider use for immunization of children from risk groups of the combined vaccines containing an acellular component; to enter into the National schedule according to epidemic indications a revaccination against pertussis of children of of 6–7 years and adults from groups of epidemiological and social risk with the subsequent step-by-step introduction of a revaccination of teenagers and adult each 10 years along with diphtheritic and tetanic anatoxins.
About the Authors
K. A. Subbotina
State Educational Institution of Higher Professional Education Perm State Medical University Ministry of Health of Russian Federation.
Russian Federation
Russian Federation
Kseniya A. Subbotina – Cand. Sci. (Med.), assistant professor of the Department of Epidemiology.
614068, Perm, Dzerzhinsky street 1 «B».
I. V. Feldblium
State Educational Institution of Higher Professional Education Perm State Medical University Ministry of Health of Russian Federation.
Russian Federation
Irina V. Feldblium – Dr. Sci. (Med.), professor, head of the Department of Epidemiology.
Russian Federation
Irina V. Feldblium – Dr. Sci. (Med.), professor, head of the Department of Epidemiology.
E. A. Kochergina
State Educational Institution of Higher Professional Education Perm State Medical University Ministry of Health of Russian Federation.
Russian Federation
Ekaterina A. Kochergina – Cand. Sci. (Med.), head of the Department of polyclinic therapy.
Russian Federation
Ekaterina A. Kochergina – Cand. Sci. (Med.), head of the Department of polyclinic therapy.
N. A. Lechtina
State Educational Institution of Higher Professional Education Perm State Medical University Ministry of Health of Russian Federation.
Russian Federation
Nadezhda A. Lechtina – intern of the Department of Epidemiology.
Russian Federation
Nadezhda A. Lechtina – intern of the Department of Epidemiology.
References
1. World Health Organization et al. Pertussis vaccines: WHO position paper – September 2015. 28 August 2015, vol. 90, 35. P. 433–460.
2. Mindlina A. Ya., Polibin R. V. About need to improve immunization against the whooping cough//Pulmonology. – 2016. – T. 26. – No. 5. – Page 560–569.
3. Centers for Disease Control and Prevention. Pertussis in other countries. 2013; http://www.cdc.gov/pertussis/countries.html.
4. Falleiros Arlant L. H., de Colsa A., Flores D., et al. Pertussis in Latin America: epidemiology and control strategies //Expert review of anti-infective therapy. – 2014. – Т. 12. – №. 10. – С. 1265–1275. doi: 10.1586/14787210.2014.948846.
5. Public Health England, Whooping cough (pertussis) statistics. Available at: https://www.gov.uk/government/publications/whooping-cough-pertussis-statistics
6. Spokes P. J., Quinn H. E., McAnulty J. M. Review of the 2008–2009 pertussis epidemic in NSW: notifications and hospitalisations //New South Wales public health bulletin. – 2010. – Т. 21. – №. 8. – С. 167–173. doi: 10.1071/NB10031.
7. Miller E., Siegrist C., Tharmaphornpilas P. WHO SAGE pertussis working group Background paper SAGE April 2014. – 2014.
8. Floret D. Pediatric deaths due to community-acquired bacterial infection. Survey of French pediatric intensive care units //Archives de pediatrie: organe officiel de la Societe francaise de pediatrie. – 2001. – Т. 8. – С. 705s-711s.
9. Briand V., Bonmarin I., Lévy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data //Vaccine. – 2007. – Т. 25. – №. 41. – С. 7224–7232.
10. Clark T. A. Changing pertussis epidemiology: everything old is new again //The Journal of infectious diseases. – 2014. – Т. 209. – №. 7. – С. 978–981. doi: 10.1093/infdis/jiu001.
11. The state report on a condition of sanitary and epidemiologic wellbeing of the population of the Russian Federation in 2014 – M.: Federal Service for the Oversight of Consumer Protection and Welfare. - 2017. – 268 pages.
12. Mooi F. R., Van Der Maas N. A. T., De Melker H. E. Pertussis resurgence: waning immunity and pathogen adaptation–two sides of the same coin //Epidemiology & Infection. – 2014. – Т. 142. – №. 4. – С. 685–694.
13. Libster R., Edwards K. M. Re-emergence of pertussis: what are the solutions? //Expert review of vaccines. – 2012. – Т. 11. – №. 11. – С. 1331–1346.
14. Tatochenko V. K. Koklyush-nedoupravlyaemaya infekciya //Voprosy` sovremennoj pediatrii. – 2014. – T. 13. – №. 2.
15. Liko J., Robison S. G., Cieslak P. R. Priming with whole-cell versus acellular pertussis vaccine //New England Journal of Medicine. – 2013. – Т. 368. – №. 6. – С. 581–582.
16. Cherry J. D. Why do pertussis vaccines fail? //Pediatrics. – 2012. – Т. 129. – №. 5. – С. 968-970.
17. Basov A. A. Epidemic process of whooping cough at the present stage: yew. – Autoref. yew.... c.m.s. Moscow, 2016.
18. MU 3.1.2943-11 «Organization and carrying out serological monitoring of a condition of collective immunity to the infections managed by means of specific prevention (diphtheria, tetanus, whooping cough, measles, a rubella, epidemic parotitis, poliomyelitis, hepatitis B)».
19. Wendelboe A. M. et al. Duration of immunity against pertussis after natural infection or vaccination //The Pediatric infectious disease journal. – 2005. – Т. 24. – №. 5. – С. S58–S61.
20. Petrova M. S., et all. Whooping cough at children of early age//Epidemiology and infectious diseases. – 2012. – No. 6.
21. Feldblyum I. V., Subbotina K.A., Nikolaeva A.M., et all. Status of immunity against diphtheria, tetanus and pertussis in adults currently // Russian immunological journal. – 2017. – T. 11. – No. 1. – Page 64–69.
22. Wendelboe A. M. et al. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants //Emerging themes in epidemiology. – 2007. – Т. 4. – №. 1. – С. 15.
23. Skoff T. H., Cynthia Kenyon, Noelle Cocoros, et al. Sources of infant pertussis infection in the United States //Pediatrics. – 2015. – Т. 136. – №. 4. – С. 635–641.
24. Ward J. I. et al. Efficacy of an acellular pertussis vaccine among adolescents and adults //New England Journal of Medicine. – 2005. – Т. 353. – №. 15. – С. 1555–1563
25. Masseria C., Krishnarajah G. The estimated incidence of pertussis in people aged 50 years old in the United States, 2006–2010 //BMC infectious diseases. – 2015. – Т. 15. – №. 1. – С. 534.
26. Stepenko A. V., Mindlina A. Ya. Risk management of development of epidemic process of whooping cough: the missed opportunities and new perspectives//the Medical almanac. – 2017. – No. 4 (49).
27. Public Health Agency of Canada. Canadian national report on immunization. CanCommunDisRep. 2006;32(S3):1,1–44.
28. Skoff T. H. et al. Early impact of the US Tdap vaccination program on pertussis trends //Archives of pediatrics & adolescent medicine. – 2012. – Т. 166. – №. 4. – С. 344-349.
29. Quinn H. E., McIntyre P. B. The impact of adolescent pertussis immunization, 2004– 2009: lessons from Australia //Bulletin of the World Health Organization. – 2011. – Т. 89. – С. 666–674.
Review
For citations:
Subbotina K.A., Feldblium I.V., Kochergina E.A., Lechtina N.A. Epidemiological Rationale for Changing the Strategy and Tactics of Vaccination of Pertussis in Current Conditions. Epidemiology and Vaccinal Prevention. 2019;18(2):27-33. (In Russ.) https://doi.org/10.31631/2073-3046-2019-18-2-27-33
Views:
765
Email this article 